This site is intended for healthcare professionals
  • Home
  • /
  • Journals
  • /
  • Cancer-associated thrombosis
  • /
  • Risk factors for cancer-associated thrombosis in p...

Risk factors for cancer-associated thrombosis in patients undergoing treatment with immune checkpoint inhibitors

Read time: 1 mins
Published:31st Jul 2020
Author: Ando Y, Hayashi T, Sugimoto R, Nishibe S, Ito K, Kawada K et al.
Availability: Free full text
Ref.:Invest New Drugs. 2020 Aug;38(4):1200-1206.
Register for free access to this exclusive healthcare learning resource

Why sign up with Medthority?

Develop your knowledge with our disease and condition focused Learning Zones

Access content from credible sources, including expert-led commentary, videos, podcasts, and webinars as well as clinical trials, treatment information and guidelines 

Personalised dashboard providing updates and recommendations for content within your areas of interest